Debio 1562M

· Debiopharm International SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Debio 1562M, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

See pricing